MR编号 | NL/H/4236/002 |
---|
药品名称 | Bortezomib Sandoz |
---|
活性成分 | |
---|
剂型 | Powder for solution for injection |
---|
上市许可持有人 | Sandoz B.V.,
The Netherlands |
---|
参考成员国 - 产品名称 | Netherlands (NL) Bortezomib Sandoz 3,5 mg poeder voor oplossing voor injectie |
---|
互认成员国 - 产品名称 | - Germany (DE)
Bortezomib HEXAL 3,5 mg - Iceland (IS)
Bortezomib Sandoz 3,5 mg Stungulyfsstofn, lausn - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Italy (IT)
- France (FR)
- Greece (GR)
- Norway (NO)
- Hungary (HU)
BORTEZOMIB SANDOZ 3,5 mg por oldatos injekcióhoz - Bulgaria (BG)
Bortezomib Zandoz - Slovenia (SI)
Bortezomib Sandoz 3,5 mg prašek za raztopino za injiciranje - Portugal (PT)
|
---|
许可日期 | 2018/03/09 |
---|
最近更新日期 | 2025/01/20 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|